A current approach to the use of antidepressants in the management of postpartum depression
DOI:
https://doi.org/10.11606/issn.1806-6976.smad.2021.159781Keywords:
Postpartum depression, Psychotropics, Antidepressant agents, SertralineAbstract
Objective: this study aimed to characterize the use of antidepressants in the management of
postpartum depression. Method: an integrative literature review of the PubMed and Virtual Health Library databases was used, with the application of descriptors, aiming to answer the guiding question of the work, between February 25th and March 10th, 2019. Based on the inclusion and exclusion criteria, 23 articles were selected that were later submitted to categorization. Results:
sertraline should be the drug of choice for the pharmacological treatment of puerperal depression. It was also found that the prophylactic use of antidepressants in susceptible women is controversial and little is known about the possible side effects. In addition, it was found that there is no consensus on the superiority of pharmacological therapy to the detriment of psychotherapies. Conclusion: there is evidence supporting the use of sertraline, paroxetine, duloxetine, nortriptyline and imipramine to treat women with postpartum depression, and breastfeeding is always recommended. It is worth noting that the need for studies with representative samples to validate or restrict the use of psychotropic drugs in the prophylaxis of puerperal depression emerges.
Downloads
References
Molenaar NM, Kamperman AM, Boyce P, Bergink. Guidelines on treatment of perinatal depression with antide¬pressants: An international review. Aust N Z J Psychiatry. 2018; 52(4): 320-7. doi: 10.1177/0004867418762057.
Anokye R, Acheampong E, Budu-Ainooson A, Obeng EI, Akwasi AG. Prevalence of postpartum depression and interventions utilized for its management. Annals Genl Psychiatry. 2018; 17(18):1-8. doi: 10.1186/s12991-018-0188-0.
Keers R, Aitchison KJ. Gender differences in antidepressant drug response. Int Rev Psychiatry. 2010; 22(5): 485-500. doi: 10.3109/09540261.2010.496448.
Munk-Olsen T, Gasse C, Laursen TM. Prevalence of antidepressant use and contacts with psy¬chiatrists and psychologists in pregnant and postpartum women. Acta Psychiatr Scand. 2012; 125(4): 318-24. doi: 10.1111/j.1600-0447.2011.01784.x.
Stein A, Murphy S, Arteche A, Lehtonen A, Harvey A, Craske MG, et al. Effects of reboxetine and citalopram on appraisal of infant facial ex¬pressions and attentional biases. J Psychopharmacol. 2012; 26(5):670-6. doi: 10.1177/0269881111421970.
Kim DR, Epperson CN, Weiss AR, Qisner KL. Pharmacotherapy of postpartum depression: an update. Expert Opin Pharmacother. 2014; 15(9): 1223-34. doi: 10.1517/14656566.2014.911842.
Souza MT de, Silva MD da, Carvalho R de. Revisão integrativa: o que é e como fazer. Einstein. 2010; 8(1): 102-6. doi: 10.1590/s1679-45082010rw1134
Langan RC, Goodbred A. Identification and Management of Peripartum Depres¬sion. Am Fam Physician. 2016; 93(10): 852-8. Available from: <https://pdfs.semanticscholar.org/37ad/f2f70f657411e65874f5d19e628838414c63.pdf>
Logsdon MC, Wisner K, Hanusa BH. Does maternal role functioning improve with antidepres¬sant treatment in women with postpartum depression? J Womens Health. 2009; 18(1): 85-90. doi: 10.1089/jwh.2007.0635.
Bloch M, Meiboom H, Lorberblatt M, Bluvstein I, Aharonov I, Schreiber S. The effect of sertraline add-on to brief dynamic psychotherapy for the treatment of postpartum depression: a randomized, double-blind, placebo-con¬trolled study. J Clin Psychiatry. 2012; 73(2): 235-41. doi: 10.4088/JCP.11m07117.
Molyneaux E, Telesia LA, Henshaw C, Boath E, Bradley E, Howard LM. Antidepressants for preventing postnatal depression (Review). Cochrane Database Syst Rev. 2018; 4(4363): 1-46. doi: 10.1002/14651858.CD004363.
Sharma V. A closer look at the preventative effect of antidepressants in postpartum depression. Arch Womens Ment Health. 2017; 20(2): 357-60. doi: 10.1007/s00737-016-0709-2.
Di Scalea TL, Wisner KL. Pharmacotherapy of postpartum depression. Expert Opin Pharmacother. 2009; 10(16): 2593-607. doi: 10.1517/14656560903277202.
O’Connor E, Senger CA, Henninger ML, Coppola E, Gaynes BN. Interventions to Prevent Perinatal Depression: A Systematic Evidence Review for the U.S. Preventive Services Task Force. Evidence Synthesis. 2019; 321(6): 588-601. doi:10.1001/jama.2018.20865.
Di Scalea LT, Wisner KL. Antidepressant medication use during breast¬feeding. Clin Obstet Gynecol. 2009; 52(3): 483-97. doi: 10.1097/GRF.0b013e3181b52bd6.
Figueiredo B, Dia CC, Brandão S, Canário C, Nunes-Costa R. Breastfeeding and postpartum depression: state of the art review. J Pediatr. 2013; 89(4): 332-8. doi: 10.1016/j.jped.2012.12.002.
Hübner-Liebermann B, Hausner H, Wittman M. Recognizing and treating peripartum de-pression. Dtsch Arztebl Int. 2012; 109(24): 419-24. doi: 10.3238/arztebl.2012.0419.
Hantsoo L, Ward-O’Brien D, Czarkowski KA, Gueorguieva R, Price LH, Epperson CN. A randomized, placebo-controlled, double-blind trial of sertra¬line for postpartum depression. Psychopharmacology. 2014;231(5): 939–48. doi: 10.1007/s00213-013-3316-1.
Chad L, Pupco A, Bozzo P, Koren G. Update on antidepressant use during breastfeeding. Can Fam Physi¬cian. 2013; 59(6): 633-4. Available from: <https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3681447/>
Andrade C. The safety of duloxetine during pregnancy and lactation. J Clin Psychiatry. 2014; 75(12): 1423-7. doi: 10.4088/JCP.14f09631.
Sie SD, Wenni JM, van Driel JJ, te Winkel AG, Boer K, Casteelen G et al. Maternal use of SSRIs, SNRIs and NaSSAs: practical recommendations during pregnancy and lactation. Arch Dis Child Fetal Neonatal Ed. 2012; 97(6): 472-6. doi: 10.1136/archdischild-2011-214239.
Cuomo A, Maina G, Neal SM, De Montis G, Rosso G, Scheggi S, et al. Using sertraline in postpartum and breastfeeding: balancing risks and benefits. Expert Opin Drug Saf. 2018; 17(7): 719-25. doi: 10.1080/14740338.2018.1491546.
Sharp DJ, Chew-Graham C, Tylee A, Lewis G, Howard L, Anderson I et al. A pragmatic randomised controlled trial to compare antidepres¬sants with a community-based psychosocial intervention for the treatment of women with postnatal depression: the RESPOND trial. Health Technol Assess. 2010; 14(43): 1-153. doi: 10.3310/hta14430.
Milgrom J, Gemmill AW, Ericksen J, Burrows G, Buist A, Reece J. Treatment of postnatal depression with cognitive behavioural therapy, sertraline and combination therapy: a randomised controlled trial. Aust N Z J Psychiatry. 2015; 49(3): 236-45. doi: 10.1177/0004867414565474.
